SCHEMBL234860

SCHEMBL234860

CCCCOC(=O)C1(C(=O)OCCCC)CCCCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
ATM Q13315 1/20 0.44
TSHR P16473 4/20 0.41
HPGD P15428 1/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
SLC6A5 Q9Y345 1/20 0.40
HCAR2 Q8TDS4 1/20 0.39
LMNA P02545 3/20 0.39
CYP3A4 P08684 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2D6 P10635 2/20 0.39
ABCB11 O95342 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM5 P08912 1/20 0.39
CHRM1 P11229 1/20 0.39
CYP2C9 P11712 1/20 0.39
CHRM3 P20309 1/20 0.39
DRD1 P21728 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16086201 0.98 ALDH1A1 (0.48) ALDH1A1ATMTSHRHPGDKMT2A
SCHEMBL17982648 0.95 NAAA (0.47) ALDH1A1ATMTSHRHCAR2LMNA
SCHEMBL16086086 0.94 NAAA (0.46) ALDH1A1ATMTSHRHCAR2LMNA
SCHEMBL6058609 0.94 ALDH1A1 (0.48) ALDH1A1ATMTSHRHPGDKMT2A
SCHEMBL27096127 0.93 ALDH1A1 (0.41) ALDH1A1ATMTSHRHPGDKMT2A
SCHEMBL16949823 0.93 NAAA (0.48) ALDH1A1TSHRHCAR2LMNANAAA
SCHEMBL2059887 0.93 NAAA (0.48) ALDH1A1TSHRHCAR2LMNANAAA
SCHEMBL588990 0.93 NAAA (0.48) ALDH1A1TSHRHCAR2LMNANAAA
SCHEMBL22361226 0.93 NAAA (0.48) ALDH1A1TSHRHCAR2LMNANAAA
SCHEMBL16949814 0.93 NAAA (0.48) ALDH1A1TSHRHCAR2LMNANAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117380209-A Catalyst for phthalate hydrogenation and preparation method and application thereof 中国石油化工股份有限公司 2024-01-12 CN claimed
US-12612313-B2 Method for producing lithium halide compound IDEMITSU KOSAN CO., LTD. (JP) 2026-04-28 US disclosed
US-20260008676-A1 METHOD FOR MANUFACTURING SULFIDE SOLID ELECTROLYTE IDEMITSU KOSAN CO.,LTD. (JP) 2026-01-08 US disclosed
EP-4657469-A1 METHOD FOR PRODUCING SULFIDE SOLID ELECTROLYTE Idemitsu Kosan Co.,Ltd. (JP) 2025-12-03 EP disclosed
EP-4159678-B1 METHOD FOR PRODUCING LITHIUM HALIDE COMPOUND IDEMITSU KOSAN CO (JP) 2025-10-01 EP disclosed
US-20250201909-A1 METHOD FOR MANUFACTURING SULFIDE SOLID ELECTROLYTE IDEMITSU KOSAN CO.,LTD. (JP) 2025-06-19 US disclosed
US-20250183359-A1 CRYSTALLINE SULFIDE SOLID ELECTROLYTE AND METHOD FOR PRODUCING SAME IDEMITSU KOSAN CO.,LTD. (JP) 2025-06-05 US disclosed
EP-4564376-A1 METHOD FOR PRODUCING SOLID ELECTROLYTE, AND SOLID ELECTROLYTE Idemitsu Kosan Co.,Ltd. (JP) 2025-06-04 EP disclosed
EP-4557317-A1 METHOD FOR MANUFACTURING SULFIDE SOLID ELECTROLYTE Idemitsu Kosan Co.,Ltd. (JP) 2025-05-21 EP disclosed
US-20250051176-A1 PRODUCTION METHOD FOR SULFIDE SOLID ELECTROLYTE AND SULFIDE SOLID ELECTROLYTE IDEMITSU KOSAN CO.,LTD. (JP) 2025-02-13 US disclosed
US-20090122243-A1 Liquid Crystal Display Device, Optical Compensatory Sheet, and Polarizer and Liquid Crystal Display Device Employing the Same FUJIFILM CORPORATION (JP) 2009-05-14 US disclosed
US-7505100-B2 Liquid crystal display device FUJIFILM CORPORATION (JP) 2009-03-17 US disclosed
CN-100462804-C Liquid crystal display device FUJI PHOTO FILM CO LTD (JP) 2009-02-18 CN disclosed
US-20080043177-A1 Liquid Crystal Display Device FUJIFILM CORPORATION (JP) 2008-02-21 US disclosed
CN-101107559-A Liquid crystal display device, optical compensatory sheet, and polarizer and liquid crystal display device employing the same FUJIFILM CORP (JP) 2008-01-16 CN disclosed
CN-101084466-A Liquid crystal display device having a plurality of pixel electrodes FUJI PHOTO FILM CO LTD (JP) 2007-12-05 CN disclosed
EP-1831758-A1 LIQUID CRYSTAL DISPLAY DEVICE, OPTICAL COMPENSATORY SHEET, AND POLARIZER AND LIQUID CRYSTAL DISPLAY DEVICE EMPLOYING THE SAME FUJIFILM Corporation (JP) 2007-09-12 EP disclosed
WO-2006070936-A1 LIQUID CRYSTAL DISPLAY DEVICE, OPTICAL COMPENSATORY SHEET, AND POLARIZER AND LIQUID CRYSTAL DISPLAY DEVICE EMPLOYING THE SAME FUJIFILM CORPORATION (JP) 2006-07-06 WO disclosed
WO-2006057461-A1 LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2006-06-01 WO disclosed
EP-0259524-A1 Polyoxyalkylene polyether amino alcohols containing a tertiary hydroxyl group and flexible polyurethanes made therefrom ARCO CHEMICAL TECHNOLOGY, INC. (US) 1988-03-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260008676-A1 METHOD FOR MANUFACTURING SULFIDE SOLID ELECTROLYTE CACNA1S, CACNA1A, VRK2 ALDH1A1 1394/4885ATM 303/4885TSHR 2677/4885
US-12612313-B2 Method for producing lithium halide compound CLCN2, SLC6A12, CLIC1 ALDH1A1 2535/4885ATM 764/4885TSHR 35/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.